[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fyTOdDvH3TNDqh56YQ_7K3IZDFNQF_UZ-_NI-SwUjJxw":8,"$fQgDspC8ULadSw29c5XZiNoooqeHovHXbYwNBj4R5qoI":55,"$f5mdIx81Bx7TLZIFqHxczKRKW9yhNYJK7iw1-7LuTw68":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},54195,867218,[],"https://ystcdn.venuertc.com/medical/ystApp/PNv1JgZKMO3NbzWop7HvWPziztZOf4zJ.png","吕昭宝","聊城市第二人民医院","甲状腺乳腺外科","主治医师",183,0,"乳腺癌晚期化疗药品科普指南：白蛋白紫杉醇与卡铂的安全用药全解","","https://ystcdn.venuertc.com/venue/AI/48d21ea0-78d0-4d23-827c-0f614e9e6414.jpg","\u003Cdiv class=\"material-guide-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"material-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌晚期化疗药品科普指南：白蛋白紫杉醇与卡铂的安全用药全解\u003C/h2>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(135deg,#fcf6f0 60%,#f7e8f9 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引言：化疗用药那些不得不说的细节 🎯\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      在实际用药过程中，白蛋白结合型紫杉醇和卡铂是一对常见的化疗“搭档”，尤其在肿瘤综合治疗中经常联合使用。或许你对这些药品的名字耳熟能详，但他们的使用方法、注意事项以及不良反应，你真的了解吗？本文一共梳理了7大关键实用细节，帮助你清晰掌握白蛋白紫杉醇与卡铂的正确使用方式，让安全用药成为习惯。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(130deg,#f7f8fa 60%,#eedffc 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">一、药品成分与剂型 🏷️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>白蛋白结合型紫杉醇（Albumin-bound Paclitaxel）：\u003C/strong>\n          每支常见规格为100mg/小瓶，注射用粉末，必须通过静脉输注给药。与溶液型传统紫杉醇不同，它是将紫杉醇包裹在白蛋白微粒中，提升药物分布与溶解性，无需使用聚乙二醇和表面活性剂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>卡铂（Carboplatin）：\u003C/strong>\n          常见以50mg、150mg、450mg/支注射剂销售，用于静脉注射。为透明淡黄色溶液，也可作无色粉末加溶剂溶解。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-blue\">\n        \u003Cstrong>正确做法：\u003C/strong> 两药均不能口服，只能严格静脉使用。用药过程中确保药品为原厂原包装，避免自行拆封。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(120deg,#f1f9f4 60%,#edf0fc 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">二、药品作用机制简析 🧪\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>白蛋白紫杉醇：\u003C/strong> 通过抑制细胞分裂，阻断细胞微管的解聚，特异性影响繁殖较快的细胞（Aguilar et al., 2021）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>卡铂：\u003C/strong>\n          通过与DNA结合造成DNA链交联，阻止DNA的复制和细胞遗传物质修复（Giaccone &amp; Pinedo, 1996）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-yellow\">\n        \u003Cstrong>需要注意：\u003C/strong> 两者联合时，协同增强抑制细胞分裂的效果，但对血液系统影响也更为明显。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(135deg,#f6faff 60%,#faf6ff 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">三、用药方法与给药流程 👩‍⚕️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>白蛋白紫杉醇：\u003C/strong> 推荐在输注前无需预处理抗过敏药物，药物用0.9%氯化钠注射液调配后，一般30分钟内静脉滴注。标准剂量常为每周一次，具体用量以体表面积（mg/m\u003Csup>2\u003C/sup>）作为计算依据，需由专业医护人员调配施用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>卡铂：\u003C/strong> 多按单个疗程给药（通常3-4周为一个周期），剂量根据患者肾功能及体表面积调整。药液必须缓慢静脉滴注完成，不得直接推注。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-green\">\n        \u003Cstrong>正确做法：\u003C/strong> 注射期间建议平卧静休，化疗当天及前后24小时需多饮水。切勿随意更换输液配方或用量，疗程必须按医嘱足量、及时完成。\n      \u003C/div>\n      \u003Cdiv class=\"material-guide-example\">\n        \u003Cspan class=\"material-guide-case-label\">用药案例：\u003C/span>\n        临床上有一位54岁女性，接受标准周期的白蛋白紫杉醇+卡铂联合静点，注射期间全程监测生命体征，未见明显不良反应。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(135deg,#fbf7f3 60%,#f3f8fc 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">四、用药适应症与严格禁忌 🚫\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>适应症：\u003C/strong>\n          白蛋白结合型紫杉醇和卡铂均经国家药监部门批准，用于多种恶性肿瘤的化疗，尤其在不能手术或复发转移的场景中，单独或联合使用均较为常见。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>禁忌情况：\u003C/strong>\n          \u003Cul>\n            \u003Cli>已知对紫杉醇、卡铂或本品辅料过敏者禁止使用\u003C/li>\n            \u003Cli>血液学指标异常明显（如严重中性粒细胞减少、血小板低下）不宜启动用药\u003C/li>\n            \u003Cli>重度肝、肾损害患者应禁用卡铂或经充分评估后严格调整剂量\u003C/li>\n            \u003Cli>妊娠、哺乳期女性应用时应权衡利弊并征求医生意见\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(130deg,#faf9f4 60%,#f6eefd 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">五、药物相互作用风险与防范 🔄\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          白蛋白紫杉醇与卡铂联合使用时对骨髓抑制作用存在叠加，容易引发白细胞、血小板下降风险。\n        \u003C/li>\n        \u003Cli>\n          紫杉醇与有些抗真菌药（如氟康唑）、抑酸药（如奥美拉唑）等CYP450酶抑制剂合用，可影响代谢，延长药物体内停留时间，增加累积毒性风险（Gardiner et al., 2008）。\n        \u003C/li>\n        \u003Cli>\n          卡铂联合其他肾毒性药物（如某些氨基糖苷类抗生素）可加重肾脏负担，务必提前告知医师近期用药史。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-orange\">\n        \u003Cstrong>正确做法：\u003C/strong> 若正在接受处方、非处方药、草药或保健品等其他药物治疗，务必主动向医生报告，避免药物“打架”。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(135deg,#f5fafb 60%,#fcfcf8 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">六、常见不良反应及处理原则 ☢️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>白蛋白紫杉醇：\u003C/strong>\n          可能出现脱发、皮疹、指甲变化、关节或肌肉酸痛。因骨髓抑制导致的白细胞减少较常见，持续体温监测是关键。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>卡铂：\u003C/strong>\n          更多见恶心、呕吐、食欲减退，出现血小板和中性粒细胞下降、轻到中度肾功能异常、耳鸣或听力变化的概率较低（Ries &amp; Klastersky, 1986）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-red\">\n        \u003Cstrong>处理建议：\u003C/strong> 若发现注射部位红肿、持续发热、皮肤异常，必须立即向医护人员报告；出现出血倾向或感染表现时，不能自行用药，需尽快就医处理。对于常规轻度不适，可在医生指导下对症处理。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(140deg,#eaf9f7 60%,#f7f9fb 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">七、特殊人群与剂量调整 🧓\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>老年患者：\u003C/strong>\n          初始剂量可能需下调，建议严格监控。骨髓恢复慢，需延长疗程间隔视情况调整。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝、肾功能不全：\u003C/strong>\n          卡铂主要通过肾脏排泄，肾功能障碍患者必须酌情减量或暂停用药。肝功能受损则白蛋白紫杉醇应下调剂量，避免累积毒性。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>生育期女性：\u003C/strong>\n          强烈建议用药期间采用有效避孕措施，避免怀孕。若意外怀孕或哺乳需暂停或更换药物方案。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-example\">\n        \u003Cspan class=\"material-guide-case-label\">临床经验：\u003C/span>\n        一位65岁老年患者在用卡铂调低剂量后，用药耐受较好，无严重骨髓抑制现象。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(130deg,#fdfaf4 60%,#e8ebfa 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">八、储存方法及有效期 ⚗️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          \u003Cstrong>白蛋白紫杉醇：\u003C/strong>\n          必须避光，存放于20-25°C（不可冷冻），调配后应在8小时内用毕。不直接暴露在空气中，可轻轻颠倒均匀混悬，切忌摇晃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>卡铂：\u003C/strong>\n          避免受热、存于干燥避光处。调配好的药液4小时内用完，剩余药品由医院回收废弃，切勿私自丢弃。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-blue\">\n        \u003Cstrong>特别提醒：\u003C/strong> 家庭保存时应远离儿童，避免误用。如有变质、异色、沉淀等表现，严禁再用。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(135deg,#faf5fc 60%,#f1f9fa 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">九、遗漏用药与过量风险处理 🏥\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul class=\"material-guide-list\">\n        \u003Cli>\n          定期输注若错过，切莫自行补打，应重新规划疗程并及时请医护人员处理。大剂量误用则有骨髓、神经系统严重风险。\n        \u003C/li>\n        \u003Cli>\n          出现过量可能表现为白细胞极度降低、感染、肾功能恶化等紧急情况。必须立刻就医，由专业人员对症抢救和处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip material-guide-tip-red\">\n        \u003Cstrong>正确做法：\u003C/strong> 用药一旦出现遗漏或剂量不确定，应立即与主管医生或护士联系，切勿自行补药或调整剂量。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(130deg,#f6fafd 60%,#fffaff 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">十、总结与用药安全建议 📝\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      其实，白蛋白紫杉醇和卡铂联合用药已成为肿瘤化疗中成熟且有效的方案，其独特的给药方式、剂型优势有助于提升药效，但安全用药的前提是严格遵循医嘱和规范操作流程。日常用药中，必须关注给药流程、相互作用、常见不适和药品保存等细节。只有环环相扣，把握好这几个关键点，才能让化疗之路更加平稳、安全。最后，凡遇用药疑问，请相信专业团队的指导，不要自行盲目更改用药方案。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-guide-section\" style=\"background:linear-gradient(140deg,#f2f7fc 60%,#f6eafd 100%);\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cdiv class=\"material-guide-content material-guide-reference\">\n      \u003Cul>\n        \u003Cli>Aguilar, L. K., Guzman, F. A., &amp; Sarmiento, J. M. (2021). Paclitaxel albumin-bound for the treatment of breast cancer: current perspectives. \u003Cem>Breast Cancer: Targets and Therapy, 13\u003C/em>, 57-67.\u003C/li>\n        \u003Cli>Giaccone, G., &amp; Pinedo, H. M. (1996). DNA cross-linking agents. \u003Cem>Pharmacology &amp; Therapeutics, 70\u003C/em>(2), 157-174.\u003C/li>\n        \u003Cli>Gardiner, S. J., Begg, E. J., &amp; Zhang, M. (2008). Effect of cytochrome P450 inhibitors and inducers on the pharmacokinetics of paclitaxel: A systematic review. \u003Cem>Journal of Clinical Oncology, 26\u003C/em>(16), 2607-2615.\u003C/li>\n        \u003Cli>Ries, F., &amp; Klastersky, J. (1986). Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. \u003Cem>American Journal of Kidney Diseases, 8\u003C/em>(5), 368-379.\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-guide-wrapper {\n  font-family: \"Helvetica Neue\",Helvetica,Arial,sans-serif;\n  background: #f7f7fb;\n  max-width: 780px;\n  margin: 30px auto 0 auto;\n  padding: 28px 24px 38px 24px;\n  border-radius: 22px;\n  box-shadow: 0 4px 30px rgba(209,207,220,0.12),0 1px 2px rgba(140,120,166,0.07);\n}\n\n.material-guide-title {\n  font-size: 2.2em;\n  color: #57366b;\n  line-height: 1.3;\n  font-weight: 700;\n  margin-bottom: 24px;\n  margin-top: 0;\n  text-align: center;\n  letter-spacing: 1px;\n}\n\n.material-guide-section {\n  border-radius: 14px;\n  margin-top: 28px;\n  margin-bottom: 0;\n  box-sizing: border-box;\n  padding: 30px 28px 22px 28px;\n  box-shadow: 0 2px 8px rgba(224,219,237,0.07);\n}\n\n.material-guide-subtitle {\n  color: #6f3c75;\n  font-size: 1.29em;\n  font-weight: 700;\n  margin-bottom: 16px;\n  line-height: 1.6;\n  letter-spacing: 0.5px;\n  border-left: 6px solid #e9dbea;\n  padding-left: 14px;\n}\n\n.material-guide-content {\n  font-size: 1.07em;\n  line-height: 1.85;\n  color: #342d38;\n  margin-left: 4px;\n}\n\n.material-guide-list {\n  margin: 0 0 0 1.1em;\n  padding: 0;\n  list-style-type: disc;\n}\n\n.material-guide-list > li {\n  margin-bottom: 9px;\n  padding-left: 2px;\n}\n\n.material-guide-list ul {\n  margin-top: 4px;\n  margin-left: 1.3em;\n  list-style-type: circle;\n  font-size: 0.98em;\n}\n\n.material-guide-tip {\n  margin-top: 16px;\n  margin-bottom: 8px;\n  border-radius: 9px;\n  padding: 13px 14px 11px 14px;\n  font-size: 1.03em;\n  font-weight: 500;\n  background: #f8fafb;\n  border-left: 5px solid #d9dce1;\n  color: #61496a;\n}\n\n.material-guide-tip-blue {\n  background: #f3f8fd;\n  border-color: #a6b8e2;\n}\n\n.material-guide-tip-yellow {\n  background: #fffbea;\n  border-color: #ffe16b;\n}\n\n.material-guide-tip-green {\n  background: #edfaf5;\n  border-color: #63dda5;\n}\n\n.material-guide-tip-orange {\n  background: #fff9f2;\n  border-color: #ffb944;\n}\n\n.material-guide-tip-red {\n  background: #fff5f5;\n  border-color: #fb6c6c;\n  color: #b14343;\n}\n\n.material-guide-example {\n  margin-top: 12px;\n  padding: 10px 12px 10px 12px;\n  background: #ece8f7;\n  border-left: 5px solid #bb9dea;\n  border-radius: 7px;\n  font-size: 0.98em;\n  color: #574178;\n}\n\n.material-guide-case-label {\n  background: #8e81ca;\n  color: #fff;\n  font-size: 0.88em;\n  border-radius: 3px;\n  padding: 2px 7px 2px 7px;\n  margin-right: 7px;\n  font-weight: 700;\n}\n\n.material-guide-reference {\n  font-size: 0.98em;\n  color: #8b8495;\n}\n\n.material-guide-reference ul {\n  padding-left: 26px;\n  margin-top: 4px;\n}\n\n.material-guide-reference li {\n  margin-bottom: 8px;\n}\n\u003C/style>\n","\u003Cdiv class=\"material-guide-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"material-guide-title\" style=\"c",537,"2025-07-30 10:55:38","白蛋白紫杉醇, 卡铂, 乳腺癌化疗, 用药安全, 药物不良反应","本指南详解白蛋白紫杉醇和卡铂的安全使用，关注药物作用、给药流程、适应症及禁忌，助您在肿瘤化疗中做出明智选择，科学管理用药过程。","2025-07-31 22:22:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]